FDA Removes “Black Box” Warning from Menopause Hormone Therapy: What Women Need to Know

For years, women considering menopause hormone therapy have faced confusing and sometimes frightening information, especially the “black box” warning placed on these medications. In a major move this year, the U.S. Food and Drug Administration (FDA) officially removed that warning from many estrogen and estrogen-progestin products.

Here’s what this means for patients.

What’s a “Black Box” Warning?

A “black box” warning is the strongest safety warning the FDA can place on a prescription medication. It appears as a bold, black border on the drug label and is meant to alert providers and patients to potentially serious risks. Black box warnings don’t mean a medication is unsafe, but they emphasize that it should be used carefully and with the right guidance from a doctor.

Why Did Menopause Medications Have It?

The warning originated from the early 2000s findings of the Women’s Health Initiative (WHI) study, which reported increased risks of breast cancer, blood clots, heart attack, and stroke in women using certain hormone therapies. At the time, the results caused widespread alarm and led to millions stopping treatment.

However, follow-up research has shown the original findings were misunderstood or exaggerated. Many participants in the WHI study were older than the typical patient starting hormone therapy, and later studies found that younger, healthier women – especially those under age 60 or within 10 years of menopause – had significantly lower risks, and in some cases, potential benefits.

Symptoms of Menopause

Menopause typically occurs in women between ages 45 and 55, and symptoms can include:

• Hot flashes and night sweats
• Irregular periods
• Vaginal dryness or discomfort
• Mood changes
• Sleep disorders
• Brain fog or difficulty concentrating
• Joint pain
• Decreased libido

For many women, these symptoms can significantly affect quality of life.

Types of Hormone Therapy Available

Treatments come in several forms, allowing women and their doctors to personalize care:

• Estrogen-only therapy (for women who’ve had a hysterectomy)
• Estrogen-progestin therapy (for women with a uterus)
• Local estrogen creams, rings, and tablets for vaginal symptoms
• Transdermal patches or gels, which absorb through the skin, may lower the risk of blood clots
• Oral tablets, commonly used for general relief

How Women Should Take Hormone Therapy

Hormone therapy should always be adjusted based on the person’s needs. In general:

• Use the lowest effective dose.
• Review treatment annually with your doctor.
• Report any unusual bleeding or side effects.
• Maintain routine screenings, such as mammograms and blood pressure checks.

Why the FDA Removed the Warning

The FDA’s recent decision reflects two decades of improved research. Today, experts agree that:

• Hormone therapy is effective for relieving moderate to severe menopause symptoms.
• Risks vary by age, health history, and type of therapy.
• For most healthy women recently entering menopause, hormone therapy is a safe, evidence-based option when used appropriately.

What This Means for Women

For women struggling with menopause symptoms, hormone therapy may now feel like a more accessible and acceptable option. The focus has shifted from broad warnings to personalized, evidence-based care, empowering women to make informed decisions about their health alongside their doctor.

If you have questions about menopause or hormone therapy, obstetrician-gynecologists at Jackson Health System are here to help you navigate your options. For more information or to make an appointment, visit https://medicalgroup.jacksonhealth.org/services/obstetrics-and-gynecology/.